spacer
spacer

PDBsum entry 2anl

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
2anl

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
327 a.a. *
Ligands
JE2 ×2
Waters ×14
* Residue conservation analysis
PDB id:
2anl
Name: Hydrolase/hydrolase inhibitor
Title: X-ray crystal structure of the aspartic protease plasmepsin 4 from the malarial parasite plasmodium malariae bound to an allophenylnorstatine based inhibitor
Structure: Plasmepsin iv. Chain: a, b. Engineered: yes
Source: Plasmodium malariae. Organism_taxid: 5858. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
3.30Å     R-factor:   0.247     R-free:   0.298
Authors: J.C.Clemente,L.Govindasamy,A.Madabushi,S.Z.Fisher,R.E.Moose, C.A.Yowell,K.Hidaka,T.Kimura,Y.Hayashi,Y.Kiso,M.Agbandje-Mckenna, J.B.Dame,B.M.Dunn,R.Mckenna
Key ref:
J.C.Clemente et al. (2006). Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor. Acta Crystallogr D Biol Crystallogr, 62, 246-252. PubMed id: 16510971 DOI: 10.1107/S0907444905041260
Date:
11-Aug-05     Release date:   04-Apr-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
O60990  (O60990_PLAMA) -  Plasmepsin from Plasmodium malariae
Seq:
Struc:
451 a.a.
327 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 

 
DOI no: 10.1107/S0907444905041260 Acta Crystallogr D Biol Crystallogr 62:246-252 (2006)
PubMed id: 16510971  
 
 
Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor.
J.C.Clemente, L.Govindasamy, A.Madabushi, S.Z.Fisher, R.E.Moose, C.A.Yowell, K.Hidaka, T.Kimura, Y.Hayashi, Y.Kiso, M.Agbandje-McKenna, J.B.Dame, B.M.Dunn, R.McKenna.
 
  ABSTRACT  
 
The malarial parasite continues to be one of the leading causes of death in many developing countries. With the development of resistance to the currently available treatments, the discovery of new therapeutics is imperative. Currently, the plasmepsin enzymes found in the food vacuole of the parasite are a chief target for drug development. Allophenylnorstatine-based compounds originally designed to inhibit HIV-1 protease have shown efficacy against all four plasmepsin enzymes found in the food vacuole of Plasmodium falciparum. In this study, the first crystal structure of P. malariae plasmepsin 4 (PmPM4) bound to the allophenylnorstatine-based compound KNI-764 is described at 3.3 A resolution. The PmPM4-inhibitor complex crystallized in the orthorhombic space group P2(1)2(1)2, with unit-cell parameters a = 95.9, b = 112.6, c = 90.4 A, with two molecules in the asymmetric unit related by a non-crystallographic symmetry operator. The structure was refined to a final R factor of 24.7%. The complex showed the inhibitor in an unexpected binding orientation with allophenylnorstatine occupying the S1' pocket. The P2 group was found outside the S2 pocket, wedged between the flap and a juxtaposed loop. Inhibition analysis of PmPM4 also suggests the potential for allophenylnorstatine-based compounds to be effective against all species of malaria infecting humans and for the future development of a broad-based inhibitor.
 
  Selected figure(s)  
 
Figure 3.
Figure 3 (a) Ribbon diagram of the PmPM4-KNI-764 complex. The PmPM4 -strands, coil and helices are colored yellow, green and red, respectively. KNI-764 is depicted in green sticks. (b) Structural superposition of the C^ trace of PmPM4-KNI-764 (blue), PvPM4-pepstatin A (red; Bernstein et al., 2003[Bernstein, N. K., Cherney, M. M., Yowell, C. A., Dame, J. B. & James, M. N. (2003). J. Mol. Biol. 329, 505-524.]), PfPM4-pepstatin A (green; Asojo et al., 2003[Asojo, O. A., Gulnik, S. V., Afonina, E., Yu, B., Ellman, J. A., Haque, T. S. & Silva, A. M. (2003). J. Mol. Biol. 327, 173-181.]) and PfPM2-Eh58 (orange; Asojo et al., 2003[Asojo, O. A., Gulnik, S. V., Afonina, E., Yu, B., Ellman, J. A., Haque, T. S. & Silva, A. M. (2003). J. Mol. Biol. 327, 173-181.]). This figure was generated using PyMOL (DeLano, 2002[DeLano, W. L. (2002). The PyMOL Molecular Graphics System. http://www.pymol.org .]).
Figure 5.
Figure 5 Stereoviews of KNI-764 in the active site of PmPM4. (a) View of P1 and P2 of KNI-764. (b) View of P1' and P2' of KNI-764. The surface of the active site is shown as a beige Connolly surface. PmPm4 is shown as a red ribbon. KNI-764 is modeled as blue sticks. The residues of the flaps (Ile75-Val82) and the 290s loop (Leu290-Glu295) are depicted as green sticks. (c) Plausible hydrogen-bonding interactions (red broken lines) between PmPM4 and KNI-764.
 
  The above figures are reprinted by permission from the IUCr: Acta Crystallogr D Biol Crystallogr (2006, 62, 246-252) copyright 2006.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21277861 H.González-Díaz, F.Prado-Prado, E.Sobarzo-Sánchez, M.Haddad, S.Maurel Chevalley, A.Valentin, J.Quetin-Leclercq, M.A.Dea-Ayuela, M.Teresa Gomez-Muños, C.R.Munteanu, J.José Torres-Labandeira, X.García-Mera, R.A.Tapia, and F.M.Ubeira (2011).
NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
  J Theor Biol, 276, 229-249.  
20221898 X.H.Ma, Z.Shi, C.Tan, Y.Jiang, M.L.Go, B.C.Low, and Y.Z.Chen (2010).
In-silico approaches to multi-target drug discovery : computer aided multi-target drug design, multi-target virtual screening.
  Pharm Res, 27, 739-749.  
19360125 N.Sturm, E.Jortzik, B.M.Mailu, S.Koncarevic, M.Deponte, K.Forchhammer, S.Rahlfs, and K.Becker (2009).
Identification of proteins targeted by the thioredoxin superfamily in Plasmodium falciparum.
  PLoS Pathog, 5, e1000383.  
18763714 J.T.Nguyen, Y.Hamada, T.Kimura, and Y.Kiso (2008).
Design of potent aspartic protease inhibitors to treat various diseases.
  Arch Pharm (Weinheim), 341, 523-535.  
17918177 M.Zürcher, T.Gottschalk, S.Meyer, D.Bur, and F.Diederich (2008).
Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
  ChemMedChem, 3, 237-240.  
17875391 P.Gayathri, H.Balaram, and M.R.Murthy (2007).
Structural biology of plasmodial proteins.
  Curr Opin Struct Biol, 17, 744-754.  
17040901 J.Liu, E.S.Istvan, and D.E.Goldberg (2006).
Hemoglobin-degrading plasmepsin II is active as a monomer.
  J Biol Chem, 281, 38682-38688.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer